Developments in multiple myeloma - immunotherapy and personalized medicine
IMiD combinations for the treatment of MM
Myeloma 2016: Panel discussion on in vivo drug screening
Caroline Heckman et al.
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
The differences in treating older versus younger CLL patients